Overview
Early-stage technology investor with healthcare among its investment specialties and AI-enabled drug discovery exposure.
Unlock the full profileGet the complete company dossier
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.